Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2008
11/04/2008US7446179 CD19-specific chimeric T cell receptor
11/04/2008US7446177 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
11/04/2008US7446176 Of given amino acid sequence; bind to antibodies; detecting integrin; diagnosing and treating disorders
11/04/2008US7446173 amino acid sequence coupled to a non-naturally-occurring polyoxyalkylene glycol at N-terminal end of glycosylated interferon-beta-1a through a coupling group such as aldehyde, maleimide, a vinylsulfone,or haloacetate groups; enhanced activity; Multiple sclerosis; cancer; therapeutical; water solubility
11/04/2008US7446172 Cytokine protein family
11/04/2008US7446171 Encoded by nucleic acid of given sequence; hybridizes to complement of nucleic acid; use as molecular weight markers,
11/04/2008US7446170 Polypeptide of given sequence; improved efficiency by using heparin binding domain derived from fibronectin; replication deficient vector
11/04/2008US7446169 Human tumor necrosis factor receptor-like 2
11/04/2008US7446168 Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) for use as a tool in treatment and prevention of urogenital and cell proliferative disorders; fertility aide
11/04/2008US7446092 Glycogen synthase kinase-3 inhibitors
11/04/2008US7446090 FSH formulation
11/04/2008US7445930 Method for the production and purification of adenoviral vectors
11/04/2008US7445928 Bacterial artificial chromosome construct encoding recombinant coronavirus
11/04/2008US7445922 Enhance effects of an endoglucanase enzyme on fabric treatment such as reduction of fuzzing, improvement in feel and appearance, color clarification, partial color change, and softening of cellulose-containing fabrics
11/04/2008US7445919 Zsig33-like peptides and polynucleotides
11/04/2008US7445914 Animal product free media and processes for obtaining a botulinum toxin
11/04/2008US7445913 Recombinant cell comprising expression vector; transcription; new cytokine that stimulates hematopoietic cells
11/04/2008US7445912 Stabilized proteins
11/04/2008US7445905 Contacting cells with receptor and determining formation of complexes; modulating gene expression in acinar cells of pancreatitis associated protein
11/04/2008US7445903 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
11/04/2008US7445901 Admixing with monoclonal antibodies; binds to ribonuclease; DNA or RNA maintains its intact, full-length form during production and storage
11/04/2008US7445890 Screening for compound that inhibits uncoupling protein (Ucp) activity; measuring expression level of reporter molecule (luciferase) in transformant; drugs for obesity, diabetes, depression
11/04/2008US7445798 Transgenic cells comprising nucleotide sequences coding fetal liver kinase-1 receptors; for use self-renewal of totipotent hematopoietic stem cell and to stimulate the development of all cells of the hematopoietic system both in vitro and in vivo
11/04/2008US7445788 Polypeptide for use in the diagnosis and detection of bacterial infections
11/04/2008US7445785 Vaccine; use in the protection of poultry against infectious bronchitis; can be administered via the in ovo route without having a negative impact on the hatchability of the vaccinated embryonated egg
11/04/2008US7445784 Apoptosis of rectum and prostate cancer
11/04/2008US7445781 Inhibits B-cell activation by binding to protein receptor on helper T-cell membrane; treatment of allergy or autoimmune disease
11/04/2008US7445775 Mammalian nucleotide sequence coding plasminogen catalytic domain and optionally kringle domains linked to promoter; ischemic stroke, arterial thrombotic diseases
11/04/2008US7445774 Glycosylated interferon α
11/04/2008US7445773 Polypeptide of given sequence which inhibits hepatitis virus replication; pegylated or recombinant; reduces viral infections and increases monocyte counts; stimulates hematopoietic cells
11/04/2008CA2486330C Stress-responsive root-specific genes
11/04/2008CA2325360C Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases
11/04/2008CA2274244C Methods for diagnosing glaucoma and discovering anti-glaucoma drugs
11/04/2008CA2223432C Radiometal-binding analogues of luteinizing hormone releasing hormone
11/04/2008CA2192849C Dna molecules which code for a plastid 2-oxoglutarate/malate translocator
11/04/2008CA2183871C Platelet growth accelerator
11/04/2008CA2182890C Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
11/01/2008CA2627079A1 Expressing glk in plants
10/2008
10/30/2008WO2008131441A1 Methods and compositions involving ltas
10/30/2008WO2008131315A2 Identification and method for using the pre-ligand assembly domain of the il-17 receptor
10/30/2008WO2008131293A2 Oriented collagen-based materials, films and methods of making same
10/30/2008WO2008131014A1 Lipopeptides and lipopeptide synthetases
10/30/2008WO2008130635A2 Formation of superfibronectin by bbk32 and uses therefor
10/30/2008WO2008130588A1 Modulation of synaptogenesis
10/30/2008WO2008130053A1 Fused protein comprising protein g with avidin
10/30/2008WO2008129851A1 Nitric oxide synthase activator
10/30/2008WO2008129838A1 Germ cell marker using fish vasa gene
10/30/2008WO2008129422A1 Demannosylated recombinant factor viii for the treatment of patients with haemophilia a
10/30/2008WO2008129180A2 Novel viii factors for the treatment of type a hemophilia
10/30/2008WO2008129103A1 Use of african swine pest haemoglutinin as an adjuvant
10/30/2008WO2008128975A1 Novel asparaginases and uses thereof
10/30/2008WO2008128974A1 Asparaginase enzyme variants and uses thereof
10/30/2008WO2008128973A2 Solutions of mannoproteins and their use
10/30/2008WO2008128972A1 Peptide mixture as wine stabiliser
10/30/2008WO2008128730A2 Antagonists of bitter taste receptors and uses thereof
10/30/2008WO2008128701A2 Yeast expression systems
10/30/2008WO2008128526A2 Use of egfl7 for stem cell modulation
10/30/2008WO2008128345A1 ENGINEERED VERSIONS OF CGTB (β-1,3- GALACTOSYLTRANSFERASE) ENZYMES, WITH ENHANCED ENZYMATIC PROPERTIES
10/30/2008WO2008128330A1 Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
10/30/2008WO2008128289A1 Modified plant defensin
10/30/2008WO2008110653B1 Antibody producing microorganism, elements required to obtain same, resulting antibodies, therapeutic compositions and use of thereof
10/30/2008WO2008108830A3 Immunogenic and therapeutic compositions for streptococcus pyogenes
10/30/2008WO2008104062A3 Selective release of pro-apoptotic bcl-2 family members and their contribution to the bystander effect
10/30/2008WO2008103471A3 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease
10/30/2008WO2008098995A9 Genes involved in mitochondrial biogenesis
10/30/2008WO2008098139A3 Axl tyrosine kinase inhibitors and methods of making and using the same
10/30/2008WO2008095905A3 Pathogen binding
10/30/2008WO2008092854A3 Papillomavirus e2 polypeptide used for vaccination
10/30/2008WO2008086524A9 Alpha-1-antitrypsin variants and uses thereof
10/30/2008WO2008078198A3 Cells and methodology to generate non-segmented negative-strand rna viruses
10/30/2008WO2008078177A3 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence
10/30/2008WO2008074329A3 Modulation of activity of proneurotrophins
10/30/2008WO2008068637A3 Ob-fold used as scaffold for engineering new specific binders
10/30/2008WO2008060510A3 Zinc finger nuclease for targeting the human glucocorticoid receptor locus
10/30/2008WO2008059523A3 Heterologous production of interleukin 1 receptor antagonist (il-1ra) in pichia pastoris
10/30/2008WO2008057709A3 Sol-gel materials for cellular modulation
10/30/2008WO2008057162A3 Native (telopeptide) placental collagen compositions
10/30/2008WO2008021379A3 Increased activity and efficiency of expansin-like proteins
10/30/2008WO2008008526A3 Treating obesity and gastro-intestinal disorders using botulinum toxin
10/30/2008WO2007125210A3 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
10/30/2008WO2007115578A8 Synthetic mecp2 sequence for protein substitution therapy
10/30/2008WO2007015886A8 Phosphorylated protein markers of gleevec-resistant chronic myelogenous leukemia
10/30/2008US20080271212 gene silencing is avoided by use of monocot-homeologous sequences from plants of the genus Coix for transformation; isolated DNA molecule that exhibits terminator activity comprising a nucleic acid sequence
10/30/2008US20080271206 Monocotyledon promoter sequences for use as tools to enhance heterologous gene expression in plants
10/30/2008US20080271200 Plants Having Improved Growth Characteristics and Method for Making the Same
10/30/2008US20080271167 for treatment of viral infection and nervous systtem disorders
10/30/2008US20080269537 Crustacean metallothionein polypeptide; bioremediation; pollution control
10/30/2008US20080269473 Expression vector comprising nucleotide sequences coding gag and pol proteins for as tool in improving exogenous gene expression
10/30/2008US20080269472 Expression vector comprising nucleotide sequences coding UP50 protein and endothelial growth factor for use in treatment of vascular disorders; regenerative medicine; tissue engineering and repair
10/30/2008US20080269464 Compositions and methods for modulating lymphocte activity
10/30/2008US20080269463 Tropoelastin Isoforms and Used Thereof
10/30/2008US20080269462 Peptide inhibitors of HIV entry
10/30/2008US20080269305 R)-N-{2-Butyl-3-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl]-3H-imidazol-4-ylmethyl}-2-(2-hydroxycarbamoyl-3-phenyl-propionylamino)succinamic Acid; AT1 receptor antagonist and neprilysin (NEP) enzyme inhibition activity; hypertension, heart failure
10/30/2008US20080269157 Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations
10/30/2008US20080269151 Antigen, nucleic acid that encodes fusion protein; diagnosis, prevention, therapy of tuberculosis
10/30/2008US20080269139 FGF-5 Supported and Binding Peptides
10/30/2008US20080269136 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
10/30/2008US20080269129 Polypeptide and dna thereof useful as a neovascular marker
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
1 ... 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 ... 2916